Related Experiment Video
Updated: Feb 18, 2026
16:31
Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
Published on: June 6, 2011
25.6K
Decompensated Cirrhosis and Fluid Resuscitation
1Department of Surgery, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
The Surgical Clinics of North America
|November 15, 2017
Summary
Critically ill patients with decompensated cirrhosis require tailored fluid resuscitation due to unique physiological changes. Understanding these alterations, particularly albumin levels, is crucial for effective treatment and improved outcomes in critical care settings.
Area of Science:
- Critical care medicine
- Hepatology
- Fluid resuscitation physiology
Background:
- Decompensated cirrhosis presents unique physiological challenges in critically ill patients.
- Alterations in albumin levels significantly impact fluid management in these patients.
- Limited data exist on specific resuscitation strategies for cirrhotic patients compared to non-liver disease populations.
Purpose of the Study:
- To enhance understanding of the unique physiology in decompensated cirrhosis.
- To guide fluid resuscitation needs for critically ill patients with cirrhosis.
- To inform clinical practice regarding albumin and saline administration.
Main Methods:
- Review of existing literature on fluid resuscitation in cirrhosis.
- Extrapolation of data from large-volume paracentesis studies.
- Analysis of physiological alterations in critically ill cirrhotic patients.
Main Results:
- Critically ill patients with decompensated cirrhosis exhibit distinct physiological profiles.
- Albumin's role in fluid balance is critical and altered in cirrhosis.
- Evidence suggests potential benefits of albumin over saline in specific scenarios.
Conclusions:
- Understanding the unique physiology of decompensated cirrhosis is essential for appropriate fluid resuscitation.
- Further research is warranted to establish optimal resuscitation protocols, including albumin use.
- Effective resuscitation can minimize morbidity and mortality in critically ill cirrhotic patients.
Related Concept Videos
01:28Esophageal Varices-II: Clinical Features and Management
641
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
641
01:30Heart Failure V: Medical Management
377
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
377
01:28Pleural Effusion II: Symptoms and Management
839
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
839
01:22Heart Failure VI: Adjunct Therapies
417
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
417
01:22Heart Failure Drugs: Diuretics
1.0K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.0K
01:24Hemodialysis II: Procedure and Complications
1.0K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.0K